nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—obesity	0.595	1	CbGaD
Trisalicylate-choline—PTGS2—ovarian follicle—obesity	0.00957	0.351	CbGeAlD
Trisalicylate-choline—Respiratory depression—Phenylpropanolamine—obesity	0.0064	0.0249	CcSEcCtD
Trisalicylate-choline—Pulmonary function test decreased—Phenylpropanolamine—obesity	0.0064	0.0249	CcSEcCtD
Trisalicylate-choline—Duodenal ulcer—Sibutramine—obesity	0.00422	0.0164	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Phendimetrazine—obesity	0.00374	0.0146	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Diethylpropion—obesity	0.00363	0.0141	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Sibutramine—obesity	0.00351	0.0137	CcSEcCtD
Trisalicylate-choline—Sweating—Benzphetamine—obesity	0.00332	0.0129	CcSEcCtD
Trisalicylate-choline—Upset stomach—Orlistat—obesity	0.00322	0.0125	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Bupropion—obesity	0.00306	0.0119	CcSEcCtD
Trisalicylate-choline—Sweating—Phendimetrazine—obesity	0.00303	0.0118	CcSEcCtD
Trisalicylate-choline—Upset stomach—Bupropion—obesity	0.00272	0.0106	CcSEcCtD
Trisalicylate-choline—Drowsiness—Phenylpropanolamine—obesity	0.0027	0.0105	CcSEcCtD
Trisalicylate-choline—Flushing—Phendimetrazine—obesity	0.00263	0.0102	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Diethylpropion—obesity	0.00241	0.00939	CcSEcCtD
Trisalicylate-choline—Hallucination—Phenylpropanolamine—obesity	0.00241	0.00937	CcSEcCtD
Trisalicylate-choline—Hallucination—Phentermine—obesity	0.00231	0.00897	CcSEcCtD
Trisalicylate-choline—Flushing—Phenylpropanolamine—obesity	0.00225	0.00874	CcSEcCtD
Trisalicylate-choline—Drowsiness—Diethylpropion—obesity	0.00225	0.00873	CcSEcCtD
Trisalicylate-choline—Drowsiness—Cimetidine—obesity	0.00214	0.00831	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Benzphetamine—obesity	0.00214	0.00831	CcSEcCtD
Trisalicylate-choline—Anorexia—Benzphetamine—obesity	0.00211	0.00819	CcSEcCtD
Trisalicylate-choline—PTGS2—gall bladder—obesity	0.00204	0.0749	CbGeAlD
Trisalicylate-choline—Hypothermia—Topiramate—obesity	0.00202	0.00787	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Topiramate—obesity	0.00202	0.00787	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Methamphetamine—obesity	0.00202	0.00785	CcSEcCtD
Trisalicylate-choline—Constipation—Methamphetamine—obesity	0.00196	0.00762	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Phendimetrazine—obesity	0.00195	0.00757	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Benzphetamine—obesity	0.00195	0.00757	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Benzphetamine—obesity	0.00192	0.00747	CcSEcCtD
Trisalicylate-choline—Anorexia—Phendimetrazine—obesity	0.00192	0.00747	CcSEcCtD
Trisalicylate-choline—Hepatitis—Cimetidine—obesity	0.00192	0.00746	CcSEcCtD
Trisalicylate-choline—Hallucination—Cimetidine—obesity	0.00191	0.00742	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Bupropion—obesity	0.00187	0.00727	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Sibutramine—obesity	0.00187	0.00725	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Sibutramine—obesity	0.00185	0.00718	CcSEcCtD
Trisalicylate-choline—Urticaria—Methamphetamine—obesity	0.00182	0.00708	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Cimetidine—obesity	0.00181	0.00705	CcSEcCtD
Trisalicylate-choline—Urticaria—Benzphetamine—obesity	0.00176	0.00683	CcSEcCtD
Trisalicylate-choline—Erythema—Diethylpropion—obesity	0.00176	0.00683	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Phendimetrazine—obesity	0.00175	0.00681	CcSEcCtD
Trisalicylate-choline—Confusional state—Phenylpropanolamine—obesity	0.00173	0.00675	CcSEcCtD
Trisalicylate-choline—Upset stomach—Topiramate—obesity	0.00173	0.00673	CcSEcCtD
Trisalicylate-choline—Constipation—Phendimetrazine—obesity	0.00172	0.0067	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Bupropion—obesity	0.00172	0.00668	CcSEcCtD
Trisalicylate-choline—Oedema—Phentermine—obesity	0.00165	0.0064	CcSEcCtD
Trisalicylate-choline—Burning sensation—Topiramate—obesity	0.00163	0.00635	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Bupropion—obesity	0.00163	0.00632	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Bupropion—obesity	0.00161	0.00626	CcSEcCtD
Trisalicylate-choline—Hypotension—Phenylpropanolamine—obesity	0.00161	0.00625	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Methamphetamine—obesity	0.00157	0.0061	CcSEcCtD
Trisalicylate-choline—Somnolence—Phenylpropanolamine—obesity	0.00153	0.00595	CcSEcCtD
Trisalicylate-choline—Stupor—Topiramate—obesity	0.00152	0.00591	CcSEcCtD
Trisalicylate-choline—Dizziness—Methamphetamine—obesity	0.00152	0.00589	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Benzphetamine—obesity	0.00151	0.00588	CcSEcCtD
Trisalicylate-choline—Constipation—Phenylpropanolamine—obesity	0.00147	0.00572	CcSEcCtD
Trisalicylate-choline—Dizziness—Benzphetamine—obesity	0.00146	0.00568	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Phentermine—obesity	0.00145	0.00564	CcSEcCtD
Trisalicylate-choline—Deafness—Bupropion—obesity	0.00144	0.00562	CcSEcCtD
Trisalicylate-choline—Headache—Methamphetamine—obesity	0.00144	0.00558	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Phenylpropanolamine—obesity	0.00142	0.00551	CcSEcCtD
Trisalicylate-choline—Constipation—Phentermine—obesity	0.00141	0.00548	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Orlistat—obesity	0.0014	0.00544	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Diethylpropion—obesity	0.00138	0.00539	CcSEcCtD
Trisalicylate-choline—Headache—Benzphetamine—obesity	0.00138	0.00538	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Phendimetrazine—obesity	0.00138	0.00536	CcSEcCtD
Trisalicylate-choline—Confusional state—Cimetidine—obesity	0.00137	0.00534	CcSEcCtD
Trisalicylate-choline—PTGS2—islet of Langerhans—obesity	0.00134	0.0491	CbGeAlD
Trisalicylate-choline—Dizziness—Phendimetrazine—obesity	0.00133	0.00518	CcSEcCtD
Trisalicylate-choline—Asthma—Orlistat—obesity	0.00132	0.00515	CcSEcCtD
Trisalicylate-choline—PTGS1—respiratory system—obesity	0.00132	0.0485	CbGeAlD
Trisalicylate-choline—Lethargy—Bupropion—obesity	0.00132	0.00513	CcSEcCtD
Trisalicylate-choline—Nausea—Benzphetamine—obesity	0.00131	0.00511	CcSEcCtD
Trisalicylate-choline—Urticaria—Phentermine—obesity	0.00131	0.00509	CcSEcCtD
Trisalicylate-choline—Asthma—Sibutramine—obesity	0.00128	0.00498	CcSEcCtD
Trisalicylate-choline—Somnolence—Diethylpropion—obesity	0.00127	0.00495	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Orlistat—obesity	0.00127	0.00493	CcSEcCtD
Trisalicylate-choline—PTGS2—respiratory system—obesity	0.00126	0.0464	CbGeAlD
Trisalicylate-choline—Headache—Phendimetrazine—obesity	0.00126	0.00491	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Diethylpropion—obesity	0.00126	0.0049	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Topiramate—obesity	0.00124	0.00482	CcSEcCtD
Trisalicylate-choline—Constipation—Diethylpropion—obesity	0.00122	0.00476	CcSEcCtD
Trisalicylate-choline—Somnolence—Cimetidine—obesity	0.00121	0.00471	CcSEcCtD
Trisalicylate-choline—Nausea—Phendimetrazine—obesity	0.0012	0.00465	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Topiramate—obesity	0.00119	0.00463	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Diethylpropion—obesity	0.00118	0.00459	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Bupropion—obesity	0.00118	0.00459	CcSEcCtD
Trisalicylate-choline—Constipation—Cimetidine—obesity	0.00117	0.00453	CcSEcCtD
Trisalicylate-choline—Weight increased—Sibutramine—obesity	0.00117	0.00453	CcSEcCtD
Trisalicylate-choline—Urticaria—Diethylpropion—obesity	0.00114	0.00443	CcSEcCtD
Trisalicylate-choline—Dizziness—Phenylpropanolamine—obesity	0.00114	0.00442	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Phentermine—obesity	0.00113	0.00438	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Cimetidine—obesity	0.00112	0.00437	CcSEcCtD
Trisalicylate-choline—Asthma—Bupropion—obesity	0.00112	0.00434	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Topiramate—obesity	0.00109	0.00426	CcSEcCtD
Trisalicylate-choline—Sweating—Sibutramine—obesity	0.00109	0.00426	CcSEcCtD
Trisalicylate-choline—Vomiting—Phenylpropanolamine—obesity	0.00109	0.00425	CcSEcCtD
Trisalicylate-choline—Dizziness—Phentermine—obesity	0.00109	0.00423	CcSEcCtD
Trisalicylate-choline—Rash—Phenylpropanolamine—obesity	0.00108	0.00422	CcSEcCtD
Trisalicylate-choline—Dermatitis—Phenylpropanolamine—obesity	0.00108	0.00422	CcSEcCtD
Trisalicylate-choline—Epistaxis—Sibutramine—obesity	0.00108	0.00419	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Bupropion—obesity	0.00107	0.00416	CcSEcCtD
Trisalicylate-choline—PTGS2—adrenal cortex—obesity	0.00106	0.0389	CbGeAlD
Trisalicylate-choline—Hepatitis—Orlistat—obesity	0.00106	0.00412	CcSEcCtD
Trisalicylate-choline—Vomiting—Phentermine—obesity	0.00105	0.00407	CcSEcCtD
Trisalicylate-choline—Rash—Phentermine—obesity	0.00104	0.00404	CcSEcCtD
Trisalicylate-choline—Dermatitis—Phentermine—obesity	0.00104	0.00403	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Topiramate—obesity	0.00104	0.00403	CcSEcCtD
Trisalicylate-choline—Headache—Phentermine—obesity	0.00103	0.00401	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—obesity	0.00102	0.365	CrCbGaD
Trisalicylate-choline—Nausea—Phenylpropanolamine—obesity	0.00102	0.00397	CcSEcCtD
Trisalicylate-choline—Weight increased—Bupropion—obesity	0.00102	0.00395	CcSEcCtD
Trisalicylate-choline—PTGS1—cardiovascular system—obesity	0.00101	0.0372	CbGeAlD
Trisalicylate-choline—Diarrhoea—Diethylpropion—obesity	0.00098	0.00381	CcSEcCtD
Trisalicylate-choline—Nausea—Phentermine—obesity	0.000978	0.0038	CcSEcCtD
Trisalicylate-choline—PTGS2—cardiovascular system—obesity	0.000968	0.0355	CbGeAlD
Trisalicylate-choline—Tinnitus—Sibutramine—obesity	0.000956	0.00372	CcSEcCtD
Trisalicylate-choline—Sweating—Bupropion—obesity	0.000954	0.00371	CcSEcCtD
Trisalicylate-choline—Dizziness—Diethylpropion—obesity	0.000947	0.00368	CcSEcCtD
Trisalicylate-choline—Epistaxis—Bupropion—obesity	0.000939	0.00365	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Cimetidine—obesity	0.000933	0.00363	CcSEcCtD
Trisalicylate-choline—Deafness—Topiramate—obesity	0.00092	0.00358	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—ALB—obesity	0.000911	0.325	CrCbGaD
Trisalicylate-choline—Vomiting—Diethylpropion—obesity	0.000911	0.00354	CcSEcCtD
Trisalicylate-choline—Rash—Diethylpropion—obesity	0.000903	0.00351	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Orlistat—obesity	0.000903	0.00351	CcSEcCtD
Trisalicylate-choline—Dermatitis—Diethylpropion—obesity	0.000902	0.00351	CcSEcCtD
Trisalicylate-choline—Dizziness—Cimetidine—obesity	0.000901	0.00351	CcSEcCtD
Trisalicylate-choline—Headache—Diethylpropion—obesity	0.000897	0.00349	CcSEcCtD
Trisalicylate-choline—PTGS1—pituitary gland—obesity	0.000897	0.0329	CbGeAlD
Trisalicylate-choline—Hepatitis—Bupropion—obesity	0.000894	0.00348	CcSEcCtD
Trisalicylate-choline—PTGS1—adipose tissue—obesity	0.000893	0.0328	CbGeAlD
Trisalicylate-choline—Hallucination—Bupropion—obesity	0.000889	0.00346	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Sibutramine—obesity	0.000874	0.0034	CcSEcCtD
Trisalicylate-choline—Salsalate—PTGS2—obesity	0.00087	0.31	CrCbGaD
Trisalicylate-choline—Vomiting—Cimetidine—obesity	0.000867	0.00337	CcSEcCtD
Trisalicylate-choline—Rash—Cimetidine—obesity	0.000859	0.00334	CcSEcCtD
Trisalicylate-choline—Dermatitis—Cimetidine—obesity	0.000859	0.00334	CcSEcCtD
Trisalicylate-choline—PTGS2—pituitary gland—obesity	0.000857	0.0315	CbGeAlD
Trisalicylate-choline—Headache—Cimetidine—obesity	0.000854	0.00332	CcSEcCtD
Trisalicylate-choline—PTGS2—adipose tissue—obesity	0.000854	0.0313	CbGeAlD
Trisalicylate-choline—Nausea—Diethylpropion—obesity	0.000851	0.00331	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Bupropion—obesity	0.000845	0.00329	CcSEcCtD
Trisalicylate-choline—PTGS1—digestive system—obesity	0.000841	0.0308	CbGeAlD
Trisalicylate-choline—Lethargy—Topiramate—obesity	0.00084	0.00327	CcSEcCtD
Trisalicylate-choline—Tinnitus—Bupropion—obesity	0.000833	0.00324	CcSEcCtD
Trisalicylate-choline—Flushing—Bupropion—obesity	0.000829	0.00323	CcSEcCtD
Trisalicylate-choline—Nausea—Cimetidine—obesity	0.00081	0.00315	CcSEcCtD
Trisalicylate-choline—PTGS2—digestive system—obesity	0.000804	0.0295	CbGeAlD
Trisalicylate-choline—PTGS1—adrenal gland—obesity	0.000801	0.0294	CbGeAlD
Trisalicylate-choline—PTGS2—adrenal gland—obesity	0.000766	0.0281	CbGeAlD
Trisalicylate-choline—Dysgeusia—Bupropion—obesity	0.000762	0.00296	CcSEcCtD
Trisalicylate-choline—Oedema—Orlistat—obesity	0.000752	0.00293	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Topiramate—obesity	0.000752	0.00292	CcSEcCtD
Trisalicylate-choline—Confusional state—Sibutramine—obesity	0.000734	0.00286	CcSEcCtD
Trisalicylate-choline—Oedema—Sibutramine—obesity	0.000728	0.00283	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Orlistat—obesity	0.000727	0.00283	CcSEcCtD
Trisalicylate-choline—Shock—Sibutramine—obesity	0.000716	0.00279	CcSEcCtD
Trisalicylate-choline—Asthma—Topiramate—obesity	0.000711	0.00277	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Sibutramine—obesity	0.000704	0.00274	CcSEcCtD
Trisalicylate-choline—PTGS1—endocrine gland—obesity	0.000695	0.0255	CbGeAlD
Trisalicylate-choline—Anorexia—Sibutramine—obesity	0.000694	0.0027	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Topiramate—obesity	0.000682	0.00265	CcSEcCtD
Trisalicylate-choline—Hypotension—Sibutramine—obesity	0.00068	0.00265	CcSEcCtD
Trisalicylate-choline—PTGS2—endocrine gland—obesity	0.000664	0.0244	CbGeAlD
Trisalicylate-choline—Dyspepsia—Orlistat—obesity	0.000662	0.00258	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Orlistat—obesity	0.000654	0.00254	CcSEcCtD
Trisalicylate-choline—Somnolence—Sibutramine—obesity	0.000647	0.00252	CcSEcCtD
Trisalicylate-choline—Weight increased—Topiramate—obesity	0.000647	0.00252	CcSEcCtD
Trisalicylate-choline—Pain—Orlistat—obesity	0.000643	0.0025	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Sibutramine—obesity	0.000641	0.00249	CcSEcCtD
Trisalicylate-choline—Confusional state—Bupropion—obesity	0.00064	0.00249	CcSEcCtD
Trisalicylate-choline—Oedema—Bupropion—obesity	0.000635	0.00247	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Sibutramine—obesity	0.000633	0.00246	CcSEcCtD
Trisalicylate-choline—Shock—Bupropion—obesity	0.000625	0.00243	CcSEcCtD
Trisalicylate-choline—Constipation—Sibutramine—obesity	0.000623	0.00242	CcSEcCtD
Trisalicylate-choline—Pain—Sibutramine—obesity	0.000623	0.00242	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Orlistat—obesity	0.00062	0.00241	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Bupropion—obesity	0.000614	0.00239	CcSEcCtD
Trisalicylate-choline—Anorexia—Bupropion—obesity	0.000605	0.00235	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Sibutramine—obesity	0.0006	0.00233	CcSEcCtD
Trisalicylate-choline—PTGS2—liver—obesity	0.000599	0.022	CbGeAlD
Trisalicylate-choline—Epistaxis—Topiramate—obesity	0.000598	0.00233	CcSEcCtD
Trisalicylate-choline—Urticaria—Orlistat—obesity	0.000598	0.00232	CcSEcCtD
Trisalicylate-choline—Hypotension—Bupropion—obesity	0.000593	0.00231	CcSEcCtD
Trisalicylate-choline—Urticaria—Sibutramine—obesity	0.000579	0.00225	CcSEcCtD
Trisalicylate-choline—Hepatitis—Topiramate—obesity	0.000569	0.00221	CcSEcCtD
Trisalicylate-choline—Hallucination—Topiramate—obesity	0.000566	0.0022	CcSEcCtD
Trisalicylate-choline—Somnolence—Bupropion—obesity	0.000564	0.00219	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Bupropion—obesity	0.000559	0.00217	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Bupropion—obesity	0.000552	0.00215	CcSEcCtD
Trisalicylate-choline—Constipation—Bupropion—obesity	0.000543	0.00211	CcSEcCtD
Trisalicylate-choline—Pain—Bupropion—obesity	0.000543	0.00211	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Topiramate—obesity	0.000538	0.00209	CcSEcCtD
Trisalicylate-choline—Pruritus—Orlistat—obesity	0.000532	0.00207	CcSEcCtD
Trisalicylate-choline—Tinnitus—Topiramate—obesity	0.000531	0.00206	CcSEcCtD
Trisalicylate-choline—Flushing—Topiramate—obesity	0.000528	0.00205	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Bupropion—obesity	0.000523	0.00203	CcSEcCtD
Trisalicylate-choline—Pruritus—Sibutramine—obesity	0.000515	0.002	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Orlistat—obesity	0.000515	0.002	CcSEcCtD
Trisalicylate-choline—Urticaria—Bupropion—obesity	0.000504	0.00196	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Sibutramine—obesity	0.000498	0.00194	CcSEcCtD
Trisalicylate-choline—Dizziness—Orlistat—obesity	0.000498	0.00194	CcSEcCtD
Trisalicylate-choline—Erythema—Topiramate—obesity	0.000496	0.00193	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Topiramate—obesity	0.000485	0.00189	CcSEcCtD
Trisalicylate-choline—Dizziness—Sibutramine—obesity	0.000482	0.00187	CcSEcCtD
Trisalicylate-choline—Vomiting—Orlistat—obesity	0.000478	0.00186	CcSEcCtD
Trisalicylate-choline—Rash—Orlistat—obesity	0.000474	0.00185	CcSEcCtD
Trisalicylate-choline—Dermatitis—Orlistat—obesity	0.000474	0.00184	CcSEcCtD
Trisalicylate-choline—Headache—Orlistat—obesity	0.000471	0.00183	CcSEcCtD
Trisalicylate-choline—Vomiting—Sibutramine—obesity	0.000463	0.0018	CcSEcCtD
Trisalicylate-choline—Rash—Sibutramine—obesity	0.000459	0.00179	CcSEcCtD
Trisalicylate-choline—Dermatitis—Sibutramine—obesity	0.000459	0.00178	CcSEcCtD
Trisalicylate-choline—Headache—Sibutramine—obesity	0.000456	0.00177	CcSEcCtD
Trisalicylate-choline—Pruritus—Bupropion—obesity	0.000449	0.00175	CcSEcCtD
Trisalicylate-choline—Nausea—Orlistat—obesity	0.000447	0.00174	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Bupropion—obesity	0.000434	0.00169	CcSEcCtD
Trisalicylate-choline—Nausea—Sibutramine—obesity	0.000433	0.00168	CcSEcCtD
Trisalicylate-choline—Dizziness—Bupropion—obesity	0.00042	0.00163	CcSEcCtD
Trisalicylate-choline—Confusional state—Topiramate—obesity	0.000408	0.00159	CcSEcCtD
Trisalicylate-choline—Oedema—Topiramate—obesity	0.000404	0.00157	CcSEcCtD
Trisalicylate-choline—Vomiting—Bupropion—obesity	0.000404	0.00157	CcSEcCtD
Trisalicylate-choline—Rash—Bupropion—obesity	0.0004	0.00156	CcSEcCtD
Trisalicylate-choline—Dermatitis—Bupropion—obesity	0.0004	0.00156	CcSEcCtD
Trisalicylate-choline—Shock—Topiramate—obesity	0.000398	0.00155	CcSEcCtD
Trisalicylate-choline—Headache—Bupropion—obesity	0.000398	0.00155	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Topiramate—obesity	0.000391	0.00152	CcSEcCtD
Trisalicylate-choline—Anorexia—Topiramate—obesity	0.000386	0.0015	CcSEcCtD
Trisalicylate-choline—Hypotension—Topiramate—obesity	0.000378	0.00147	CcSEcCtD
Trisalicylate-choline—Nausea—Bupropion—obesity	0.000377	0.00147	CcSEcCtD
Trisalicylate-choline—Somnolence—Topiramate—obesity	0.00036	0.0014	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Topiramate—obesity	0.000356	0.00138	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Topiramate—obesity	0.000352	0.00137	CcSEcCtD
Trisalicylate-choline—Constipation—Topiramate—obesity	0.000346	0.00135	CcSEcCtD
Trisalicylate-choline—Pain—Topiramate—obesity	0.000346	0.00135	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Topiramate—obesity	0.000333	0.0013	CcSEcCtD
Trisalicylate-choline—Urticaria—Topiramate—obesity	0.000321	0.00125	CcSEcCtD
Trisalicylate-choline—Pruritus—Topiramate—obesity	0.000286	0.00111	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Topiramate—obesity	0.000277	0.00108	CcSEcCtD
Trisalicylate-choline—Dizziness—Topiramate—obesity	0.000267	0.00104	CcSEcCtD
Trisalicylate-choline—Vomiting—Topiramate—obesity	0.000257	0.001	CcSEcCtD
Trisalicylate-choline—Rash—Topiramate—obesity	0.000255	0.000992	CcSEcCtD
Trisalicylate-choline—Dermatitis—Topiramate—obesity	0.000255	0.000991	CcSEcCtD
Trisalicylate-choline—Headache—Topiramate—obesity	0.000253	0.000985	CcSEcCtD
Trisalicylate-choline—Nausea—Topiramate—obesity	0.00024	0.000934	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism—OXCT1—obesity	6.94e-05	0.000587	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYTB—obesity	6.94e-05	0.000587	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACACB—obesity	6.94e-05	0.000587	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FADS1—obesity	6.81e-05	0.000576	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PCK1—obesity	6.81e-05	0.000576	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HADH—obesity	6.81e-05	0.000576	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PNLIP—obesity	6.76e-05	0.000572	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SRD5A1—obesity	6.76e-05	0.000572	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LPL—obesity	6.7e-05	0.000567	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACP5—obesity	6.62e-05	0.00056	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SDC3—obesity	6.6e-05	0.000558	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GGT1—obesity	6.57e-05	0.000555	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GPX1—obesity	6.54e-05	0.000553	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—obesity	6.47e-05	0.000547	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—G6PD—obesity	6.45e-05	0.000546	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PCK1—obesity	6.45e-05	0.000546	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HK2—obesity	6.45e-05	0.000546	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—STS—obesity	6.45e-05	0.000546	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP26B1—obesity	6.45e-05	0.000546	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HK1—obesity	6.37e-05	0.000539	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SREBF2—obesity	6.37e-05	0.000539	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—obesity	6.37e-05	0.000539	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CD36—obesity	6.37e-05	0.000539	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARD—obesity	6.31e-05	0.000534	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ACP5—obesity	6.28e-05	0.000531	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	6.24e-05	0.000528	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC27A1—obesity	6.18e-05	0.000523	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPA—obesity	6.16e-05	0.000521	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—G6PD—obesity	6.12e-05	0.000517	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GLUL—obesity	6.06e-05	0.000513	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FABP4—obesity	6.06e-05	0.000513	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HK1—obesity	6.04e-05	0.000511	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPIN1—obesity	6.02e-05	0.00051	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARA—obesity	5.92e-05	0.000501	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA5—obesity	5.9e-05	0.000499	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—obesity	5.86e-05	0.000496	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	5.84e-05	0.000494	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UCP2—obesity	5.75e-05	0.000486	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UCP3—obesity	5.75e-05	0.000486	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ECHS1—obesity	5.75e-05	0.000486	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD11B1—obesity	5.75e-05	0.000486	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AGT—obesity	5.73e-05	0.000485	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADH1B—obesity	5.65e-05	0.000478	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC22A1—obesity	5.63e-05	0.000476	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CLOCK—obesity	5.63e-05	0.000476	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOE—obesity	5.62e-05	0.000475	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOB—obesity	5.57e-05	0.000471	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPAM—obesity	5.57e-05	0.000471	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACSL1—obesity	5.57e-05	0.000471	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARGC1B—obesity	5.57e-05	0.000471	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CAV1—obesity	5.57e-05	0.000471	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOA1—obesity	5.55e-05	0.00047	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GLP1R—obesity	5.49e-05	0.000464	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SULT2A1—obesity	5.49e-05	0.000464	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HADH—obesity	5.4e-05	0.000457	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PCK1—obesity	5.4e-05	0.000457	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FADS1—obesity	5.4e-05	0.000457	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—DPYD—obesity	5.4e-05	0.000457	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LPL—obesity	5.32e-05	0.00045	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—obesity	5.3e-05	0.000449	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	5.29e-05	0.000448	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACP5—obesity	5.26e-05	0.000445	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RBP4—obesity	5.2e-05	0.00044	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PRKAR2B—obesity	5.2e-05	0.00044	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GPX1—obesity	5.19e-05	0.000439	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—DCN—obesity	5.16e-05	0.000436	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—G6PD—obesity	5.12e-05	0.000433	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	5.07e-05	0.000429	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SREBF2—obesity	5.06e-05	0.000428	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HK1—obesity	5.06e-05	0.000428	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CD36—obesity	5.05e-05	0.000428	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CPT1A—obesity	5.02e-05	0.000425	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—obesity	4.94e-05	0.000418	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CST3—obesity	4.93e-05	0.000417	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKAR2B—obesity	4.93e-05	0.000417	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NAMPT—obesity	4.92e-05	0.000416	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARG—obesity	4.89e-05	0.000414	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LIPC—obesity	4.89e-05	0.000414	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCK—obesity	4.89e-05	0.000414	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—DCN—obesity	4.89e-05	0.000414	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPA—obesity	4.89e-05	0.000413	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOC3—obesity	4.86e-05	0.000411	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—POMC—obesity	4.83e-05	0.000408	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPIN1—obesity	4.78e-05	0.000405	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NCF2—obesity	4.76e-05	0.000402	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CETP—obesity	4.72e-05	0.000399	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARA—obesity	4.7e-05	0.000398	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA5—obesity	4.69e-05	0.000396	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SDC1—obesity	4.67e-05	0.000395	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NAMPT—obesity	4.66e-05	0.000395	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GCK—obesity	4.64e-05	0.000392	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOC3—obesity	4.61e-05	0.00039	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IAPP—obesity	4.61e-05	0.00039	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKR1C3—obesity	4.59e-05	0.000388	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AGT—obesity	4.55e-05	0.000385	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SCARB1—obesity	4.52e-05	0.000382	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	4.5e-05	0.000381	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC22A1—obesity	4.47e-05	0.000378	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CLOCK—obesity	4.47e-05	0.000378	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOE—obesity	4.46e-05	0.000377	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	4.46e-05	0.000377	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SDC1—obesity	4.42e-05	0.000374	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CAV1—obesity	4.42e-05	0.000374	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOA1—obesity	4.41e-05	0.000373	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—obesity	4.4e-05	0.000372	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SREBF1—obesity	4.39e-05	0.000371	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SULT2A1—obesity	4.36e-05	0.000368	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GLP1R—obesity	4.36e-05	0.000368	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKR1C3—obesity	4.35e-05	0.000368	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—DPYD—obesity	4.28e-05	0.000363	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GOT2—obesity	4.27e-05	0.000361	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	4.21e-05	0.000356	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FASN—obesity	4.18e-05	0.000353	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—BCHE—obesity	4.16e-05	0.000352	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PRKAR2B—obesity	4.12e-05	0.000349	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—DCN—obesity	4.1e-05	0.000346	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GOT2—obesity	4.04e-05	0.000342	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	4.02e-05	0.00034	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2E1—obesity	4.01e-05	0.000339	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CPT1A—obesity	3.98e-05	0.000337	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NQO1—obesity	3.97e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FASN—obesity	3.96e-05	0.000335	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PARP1—obesity	3.94e-05	0.000333	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NAMPT—obesity	3.91e-05	0.000331	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.88e-05	0.000329	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARG—obesity	3.88e-05	0.000329	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LIPC—obesity	3.88e-05	0.000328	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCK—obesity	3.88e-05	0.000328	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOC3—obesity	3.86e-05	0.000326	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.85e-05	0.000326	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—POMC—obesity	3.83e-05	0.000324	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GCG—obesity	3.8e-05	0.000322	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC2A4—obesity	3.8e-05	0.000322	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYCS—obesity	3.75e-05	0.000318	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CETP—obesity	3.75e-05	0.000317	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS1—obesity	3.71e-05	0.000314	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SDC1—obesity	3.7e-05	0.000313	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GGT1—obesity	3.68e-05	0.000312	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GOT1—obesity	3.68e-05	0.000312	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—obesity	3.68e-05	0.000311	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TCF7L2—obesity	3.67e-05	0.00031	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKR1C3—obesity	3.64e-05	0.000308	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOA1—obesity	3.63e-05	0.000307	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC2A4—obesity	3.6e-05	0.000305	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SCARB1—obesity	3.59e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP19A1—obesity	3.58e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—STK11—obesity	3.58e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.54e-05	0.000299	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—obesity	3.49e-05	0.000295	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GOT1—obesity	3.49e-05	0.000295	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SREBF1—obesity	3.48e-05	0.000295	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRL—obesity	3.44e-05	0.000291	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GOT2—obesity	3.39e-05	0.000287	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.34e-05	0.000283	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—COMT—obesity	3.32e-05	0.000281	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FASN—obesity	3.31e-05	0.00028	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—BCHE—obesity	3.3e-05	0.000279	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARGC1A—obesity	3.28e-05	0.000277	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GNB3—obesity	3.28e-05	0.000277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FOXO3—obesity	3.27e-05	0.000277	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMOX1—obesity	3.26e-05	0.000276	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GNAS—obesity	3.19e-05	0.00027	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2E1—obesity	3.18e-05	0.000269	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NQO1—obesity	3.15e-05	0.000266	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOB—obesity	3.13e-05	0.000264	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.08e-05	0.000261	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC2A4—obesity	3.02e-05	0.000255	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GCG—obesity	3.02e-05	0.000255	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPL—obesity	2.98e-05	0.000252	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYCS—obesity	2.98e-05	0.000252	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOB—obesity	2.96e-05	0.000251	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GOT1—obesity	2.92e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GGT1—obesity	2.92e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPX1—obesity	2.91e-05	0.000246	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOA1—obesity	2.88e-05	0.000244	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—STK11—obesity	2.84e-05	0.00024	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP19A1—obesity	2.84e-05	0.00024	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CD36—obesity	2.84e-05	0.00024	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LPL—obesity	2.83e-05	0.000239	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FOXO1—obesity	2.81e-05	0.000238	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—obesity	2.69e-05	0.000227	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—COMT—obesity	2.64e-05	0.000223	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARA—obesity	2.64e-05	0.000223	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCD—obesity	2.61e-05	0.000221	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GNB3—obesity	2.6e-05	0.00022	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARGC1A—obesity	2.6e-05	0.00022	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMOX1—obesity	2.59e-05	0.000219	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AGT—obesity	2.55e-05	0.000216	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—obesity	2.55e-05	0.000215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GNAS—obesity	2.53e-05	0.000214	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOE—obesity	2.5e-05	0.000212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOB—obesity	2.48e-05	0.00021	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAV1—obesity	2.48e-05	0.00021	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA1—obesity	2.47e-05	0.000209	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS2—obesity	2.42e-05	0.000205	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOE—obesity	2.37e-05	0.000201	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPL—obesity	2.37e-05	0.0002	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.37e-05	0.0002	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CAV1—obesity	2.35e-05	0.000199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOA1—obesity	2.34e-05	0.000198	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPX1—obesity	2.31e-05	0.000196	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CG—obesity	2.26e-05	0.000191	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CD36—obesity	2.25e-05	0.00019	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BAD—obesity	2.21e-05	0.000187	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARG—obesity	2.18e-05	0.000184	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—POMC—obesity	2.15e-05	0.000182	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—INS—obesity	2.14e-05	0.000181	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—obesity	2.13e-05	0.00018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS1—obesity	2.12e-05	0.000179	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARA—obesity	2.09e-05	0.000177	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AGT—obesity	2.03e-05	0.000171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—INS—obesity	2.03e-05	0.000171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOE—obesity	1.99e-05	0.000168	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CD—obesity	1.98e-05	0.000168	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAV1—obesity	1.97e-05	0.000166	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA1—obesity	1.96e-05	0.000166	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—obesity	1.96e-05	0.000166	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT2—obesity	1.96e-05	0.000166	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CD—obesity	1.88e-05	0.000159	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.88e-05	0.000159	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—obesity	1.87e-05	0.000159	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3R1—obesity	1.87e-05	0.000159	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SERPINE1—obesity	1.86e-05	0.000157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TYK2—obesity	1.81e-05	0.000153	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RHOA—obesity	1.79e-05	0.000152	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CG—obesity	1.79e-05	0.000152	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3R1—obesity	1.78e-05	0.00015	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—obesity	1.78e-05	0.00015	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CB—obesity	1.73e-05	0.000146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARG—obesity	1.73e-05	0.000146	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—obesity	1.71e-05	0.000145	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—POMC—obesity	1.71e-05	0.000144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—INS—obesity	1.7e-05	0.000144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTOR—obesity	1.64e-05	0.000139	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CB—obesity	1.64e-05	0.000139	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CD—obesity	1.58e-05	0.000133	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—obesity	1.56e-05	0.000132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—obesity	1.49e-05	0.000126	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3R1—obesity	1.49e-05	0.000126	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CB—obesity	1.37e-05	0.000116	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—obesity	1.27e-05	0.000107	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYC—obesity	1.18e-05	9.96e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—obesity	1.17e-05	9.94e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CA—obesity	1.05e-05	8.92e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CA—obesity	1e-05	8.46e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—obesity	8.85e-06	7.49e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—obesity	8.61e-06	7.29e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CA—obesity	8.37e-06	7.08e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—obesity	8.17e-06	6.91e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—obesity	6.84e-06	5.79e-05	CbGpPWpGaD
